HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlo Genova Selected Research

Carlo Genova Research Topics

Disease

62Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 06/2012
39Neoplasms (Cancer)
08/2022 - 07/2012
18Lung Neoplasms (Lung Cancer)
03/2022 - 07/2012
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2022 - 07/2014
6Disease Progression
03/2021 - 06/2012
5Neoplasm Metastasis (Metastasis)
01/2022 - 10/2016
5Circulating Neoplastic Cells
12/2019 - 01/2014
4COVID-19
08/2022 - 01/2020
4Breast Neoplasms (Breast Cancer)
01/2021 - 01/2015
3Malignant Mesothelioma
04/2022 - 01/2016
3Adenocarcinoma of Lung
10/2016 - 06/2015
2Inflammation (Inflammations)
01/2022 - 06/2021
2Melanoma (Melanoma, Malignant)
01/2019 - 07/2012
2Carcinoma (Carcinomatosis)
01/2019 - 01/2018
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2016 - 01/2016
1Infections
08/2022
1Asymptomatic Infections
08/2022
1Gastritis
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Sarcoma (Soft Tissue Sarcoma)
03/2021
1Persistent Infection
01/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1Hodgkin Disease (Hodgkin's Disease)
01/2021
1Second Primary Neoplasms (Neoplasms, Second)
01/2021
1Obesity
10/2020
1Overweight
10/2020
1Thyroid Diseases (Thyroid Disease)
01/2020
1Hypertension (High Blood Pressure)
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
01/2020

Drug/Important Bio-Agent (IBA)

20Immune Checkpoint InhibitorsIBA
03/2022 - 01/2018
13Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2014
12NivolumabIBA
06/2021 - 01/2018
6Tyrosine Kinase InhibitorsIBA
05/2021 - 08/2014
6pembrolizumabIBA
01/2021 - 10/2020
5Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2016
5Monoclonal AntibodiesIBA
01/2021 - 07/2012
4PlatinumIBA
03/2022 - 01/2018
4Biological ProductsIBA
01/2022 - 10/2014
4LigandsIBA
01/2022 - 01/2019
4ErbB Receptors (EGF Receptor)IBA
05/2021 - 09/2015
4B7-H1 AntigenIBA
01/2021 - 01/2019
4MicroRNAs (MicroRNA)IBA
12/2019 - 01/2016
4Cell-Free Nucleic AcidsIBA
07/2019 - 12/2015
4DNA (Deoxyribonucleic Acid)IBA
03/2019 - 12/2015
4Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2018 - 06/2012
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 11/2017
3Pharmaceutical PreparationsIBA
01/2021 - 08/2013
3Pemetrexed (MTA)FDA Link
12/2018 - 08/2013
3AfatinibIBA
12/2018 - 04/2014
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2018 - 01/2016
2Anaplastic Lymphoma KinaseIBA
01/2022 - 03/2021
2osimertinibIBA
05/2021 - 01/2019
2CTLA-4 AntigenIBA
01/2021 - 07/2012
2Phosphotransferases (Kinase)IBA
01/2020 - 01/2016
2Messenger RNA (mRNA)IBA
01/2019 - 01/2018
2AntibodiesIBA
01/2019 - 01/2018
2Circulating Tumor DNAIBA
01/2019 - 11/2017
2VaccinesIBA
01/2018 - 07/2012
2Oxygen (Dioxygen)IBA
01/2018 - 08/2013
2necitumumabIBA
01/2018 - 01/2016
2SolutionsIBA
01/2017 - 01/2016
2Formaldehyde (Formol)FDA Link
01/2016 - 12/2015
2ParaffinIBA
01/2016 - 12/2015
2Gefitinib (Iressa)FDA Link
06/2015 - 06/2012
2IpilimumabIBA
07/2014 - 07/2012
1Carboplatin (JM8)FDA LinkGeneric
03/2022
1Bevacizumab (Avastin)FDA Link
03/2022
1atezolizumabIBA
03/2022
1Etoposide (VP 16)FDA LinkGeneric
03/2022
1brigatinibIBA
01/2022
1C-Reactive ProteinIBA
01/2022
1ProcalcitoninIBA
01/2022
1human ERBB2 proteinIBA
03/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1Brentuximab VedotinIBA
01/2021
1Ado-Trastuzumab EmtansineIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1AntigensIBA
01/2021
1Cytotoxins (Cytolysins)IBA
01/2021
1Hormones (Hormone)IBA
01/2021
1Immunologic Factors (Immunomodulators)IBA
01/2021
1Long-Acting Thyroid Stimulator (LATS)IBA
01/2021
1Estrogen ReceptorsIBA
01/2021
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2021
1SteroidsIBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1Proton Pump InhibitorsIBA
01/2021
1Cytostatic AgentsIBA
01/2021
1Adenosine Diphosphate Ribose (ADP-Ribose)IBA
04/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2020
1ORALIT (ORS)IBA
01/2020

Therapy/Procedure

23Therapeutics
08/2022 - 06/2012
17Immunotherapy
04/2022 - 01/2014
11Drug Therapy (Chemotherapy)
03/2022 - 08/2014
3Precision Medicine
01/2022 - 01/2015
2Lasers (Laser)
01/2018 - 01/2017
1Radiotherapy
01/2021
1Critical Care (Surgical Intensive Care)
01/2020
1Continuity of Patient Care
01/2020